Evidence map›Paper›PMID 40195926›Full record

ArticleJournal of Korean medical science2025

Association of Age, Sex and Education With Access to the Intravenous Thrombolysis for Acute Ischemic Stroke.

Yoona Ko, Beom Joon Kim, Youngran Kim, Jong-Moo Park, Kyusik Kang, Jae Guk Kim, Jae-Kwan Cha, Tai Hwan Park, Kyungbok Lee, Jun Lee and 20 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of Korean medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Tenecteplase for Minor Stroke: Does Sex Matter?Journal of the American Heart Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Yoona KoDepartment of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.ORCID https://orcid.org/0009-0002-7688-495X
Beom Joon KimDepartment of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea. Kim.BJ.Stroke@gmail.com.ORCID https://orcid.org/0000-0002-2719-3012
Youngran KimDepartment of Management, Policy & Community Health, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID https://orcid.org/0000-0002-2063-5017
Jong-Moo ParkDepartment of Neurology, Uijeongbu Eulji Medical Center, Eulji University, Uijenongbu, Korea.ORCID https://orcid.org/0000-0002-4199-3024
Kyusik KangDepartment of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-4021-4439
Jae Guk KimDepartment of Neurology, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon, Korea.ORCID https://orcid.org/0000-0003-1418-0033
Jae-Kwan ChaDepartment of Neurology, Dong-A University Hospital, Busan, Korea.ORCID https://orcid.org/0000-0002-1049-5196
Tai Hwan ParkDepartment of Neurology, Seoul Medical Center, Seoul, Korea.ORCID https://orcid.org/0000-0002-5148-1663
Kyungbok LeeDepartment of Neurology, Soonchunhyang University Seoul Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0003-2663-7483
Jun LeeDepartment of Neurology, Yeungnam University Medical Center, Daegu, Korea.ORCID https://orcid.org/0000-0001-8643-0797
Keun-Sik HongDepartment of Neurology, Inje University Ilsan Paik Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0002-4684-6111
Byung-Chul LeeDepartment of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea.ORCID https://orcid.org/0000-0002-3885-981X
Kyung-Ho YuDepartment of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea.ORCID https://orcid.org/0000-0002-8997-5626
Dong-Eog KimDepartment of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0002-9339-6539
Joon-Tae KimDepartment of Neurology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.ORCID https://orcid.org/0000-0003-4028-8339
Jay Chol ChoiDepartment of Neurology, Jeju National University Hospital, Jeju, Korea.ORCID https://orcid.org/0000-0002-3550-2196
Jee Hyun KwonDepartment of Neurology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.ORCID https://orcid.org/0000-0002-5894-3146
Wook-Joo KimDepartment of Neurology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.ORCID https://orcid.org/0000-0001-5290-0623
Kyu Sun YumDepartment of Neurology, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea.ORCID https://orcid.org/0000-0001-9815-7652
Sung-Il SohnDepartment of Neurology, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.ORCID https://orcid.org/0000-0002-6900-1242
Hyungjong ParkDepartment of Neurology, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea.ORCID https://orcid.org/0000-0002-6112-2939
Sang-Hwa LeeDepartment of Neurology, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Korea.ORCID https://orcid.org/0000-0002-0609-1551
Kwang-Yeol ParkDepartment of Neurology, Chung-Ang University Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0003-4570-3538
Chi Kyung KimDepartment of Neurology, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-0423-7297
Sung Hyuk HeoDepartment of Neurology, Kyung Hee University Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-9215-5119
Moon-Ku HanDepartment of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea.ORCID https://orcid.org/0000-0003-0166-387X
Anjail Z SharriefDepartment of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID https://orcid.org/0000-0002-9814-6715
Sunil A ShethDepartment of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID https://orcid.org/0000-0003-0602-8509
Hee-Joon BaeDepartment of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea.ORCID https://orcid.org/0000-0003-0051-1997
CRCS-K Investigators

Funding

Ministry of Health and Welfare HI22C0454
6 · The paper itself

Abstract

backgroundBarriers to treatment with intravenous thrombolysis (IVT) for patients with acute ischemic stroke (AIS) in South Korea remain incompletely characterized. We analyze a nationwide prospective cohort to determine patient-level features associated with delayed presentation and non-treatment of potential IVT-eligible patients.

methodsWe identified consecutive patients with AIS from 01/2011 to 08/2023 from a multicenter and prospective acute stroke registry in Korea. Patients were defined as IVT candidates if they presented within 4.5 hours from the last known well, had no lab evidence of coagulopathy, and had National Institute of Health Stroke Scale (NIHSS) ≥ 4. Multivariable generalized linear mixed regression models were used to investigate the associations between their characteristics and the IVT candidates or the use of IVT among the candidates.

resultsAmong 84,103 AIS patients, 41.0% were female, with a mean age of 69 ± 13 years and presentation NIHSS of 4 [interquartile range, 1-8]. Out of these patients, 13,757 (16.4%) were eligible for IVT, of whom 8,179 (59.5%) received IVT. Female sex (adjusted risk ratio [RR], 0.90; 95% confidence interval [CI], 0.86-0.94) and lower years of education (adjusted RR, 0.90; 95% CI, 0.84-0.97 for 0-3 years, compared to ≥ 13 years) were associated with a decreased likelihood of presenting as eligible for IVT after AIS; meanwhile, young age (adjusted RR, 1.12; 95% CI, 1.01-1.24 for ≤ 44 years, compared to 75-84 years) was associated with an increased likelihood of being an IVT candidate. Among those who were eligible for IVT, only age was significantly associated with the use of IVT (adjusted RR, 1.09; 95% CI, 1.03-1.16 for age 65-74 and adjusted RR, 0.83; 95% CI, 0.76-0.90 for ≥ 85 years, respectively).

conclusionMost patients with AIS present outside IVT eligibility in South Korea, and only 60% of eligible patients were ultimately treated. We identified increased age, female sex and lower education as key features on which to focus interventions for improving IVT utilization.

Indexed as

Ischemic StrokeStrokeThrombolytic TherapyAdministration, IntravenousAgedAged, 80 and overAge FactorsEducational StatusFemaleFibrinolytic AgentsHumansMaleMiddle AgedOdds RatioProspective StudiesRegistriesFibrinolytic AgentsTissue Plasminogen ActivatorDisparityIntravenous ThrombolysisSouth KoreaStroke

Identifiers

PMID40195926
PMCPMC11976105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.